High-dose busulfan is a major risk factor for ovarian dysfunction in girls after stem cell transplantation

Naoko Maeda, Koji Kato, Takaharu Matsuyama, Seiji Kojima, Kenji Ohyama

研究成果: ジャーナルへの寄稿学術誌査読

6 被引用数 (Scopus)

抄録

We studied gonadal function in 42 girls who underwent stem cell transplantation (SCT) between 1982 and 1997. Their median age at the time of transplantation was 11 years (range: 5 to 16 years), and that at the time of the study was 17 years (range: 13 to 27 years). Diagnoses included acute leukemia (n=25), aplastic anemia (n=12), chronic myelogenous leukemia (n=3) and lymphoma (n=2). They were assigned to one of four groups according to the preconditioning regimen used for SCT; busulfan plus melphalan (BU group; n=17), high-dose chemotherapy plus total body irradiation (TBI group; n=15), cyclophosphamide plus total lymphoid irradiation (TLI group; n=7), and all others (n=3). Gonadal function was assessed by occurrence of menstruation, serum levels of LH, FSH, and estradiol (E2). Twenty-eight of forty-two patients (67%) had no menstruation after SCT. The percentages of patients with amenorrhea were 100%, 60% and 14% in the BU, TBI and TLI groups, respectively. These findings confirm that a busulfan plus melphalan regimen is a major risk factor for ovarian dysfunction in children after SCT. Copyright

本文言語英語
ページ(範囲)13-18
ページ数6
ジャーナルClinical Pediatric Endocrinology
12
1
DOI
出版ステータス出版済み - 2003
外部発表はい

!!!All Science Journal Classification (ASJC) codes

  • 小児科学、周産期医学および子どもの健康
  • 内分泌学、糖尿病および代謝内科学
  • 内分泌学

フィンガープリント

「High-dose busulfan is a major risk factor for ovarian dysfunction in girls after stem cell transplantation」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル